These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1233266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Stimulation of drug metabolism by rifampicin in patients with cirrhosis or cholestasis measured by increased hexobarbital and tolbutamide clearance.
    Zilly W, Breimer DD, Richter E.
    Eur J Clin Pharmacol; 1977 Apr 20; 11(4):287-93. PubMed ID: 862650
    [Abstract] [Full Text] [Related]

  • 3. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD, Zilly W, Richter E.
    Clin Pharmacol Ther; 1977 Apr 20; 21(4):470-81. PubMed ID: 849678
    [Abstract] [Full Text] [Related]

  • 4. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM, Teunissen MW, Breimer DD.
    Drug Metab Dispos; 1981 Apr 20; 9(6):541-4. PubMed ID: 6120813
    [Abstract] [Full Text] [Related]

  • 5. Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.
    Richter E, Breimer DD, Zilly W.
    Eur J Clin Pharmacol; 1980 Apr 20; 17(3):197-202. PubMed ID: 7363932
    [Abstract] [Full Text] [Related]

  • 6. Effect of diethyldithiocarbamate on the metabolic elimination of hexobarbital, phenazone, tolbutamide and four halogenated hydrocarbons.
    Siegers CP, Biltz H, Pentz R.
    Eur J Drug Metab Pharmacokinet; 1981 Apr 20; 6(2):141-8. PubMed ID: 6268415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.
    Smith DA, Chandler MH, Shedlofsky SI, Wedlund PJ, Blouin RA.
    Br J Clin Pharmacol; 1991 Dec 20; 32(6):735-9. PubMed ID: 1768567
    [Abstract] [Full Text] [Related]

  • 9. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
    Zilly W, Wernze H, Buchenau D, Breimer DD, Richter E.
    Verh Dtsch Ges Inn Med; 1975 Dec 20; 81():1677-80. PubMed ID: 1227056
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic interactions with rifampicin.
    Zilly W, Breimer DD, Richter E.
    Clin Pharmacokinet; 1977 Dec 20; 2(1):61-70. PubMed ID: 140033
    [Abstract] [Full Text] [Related]

  • 11. Influence of corticosteroid on hexobarbital and tolbutamide disposition.
    Breimer DD, Zilly W, Richter E.
    Clin Pharmacol Ther; 1978 Aug 20; 24(2):208-12. PubMed ID: 679598
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery.
    Breimer DD, Zilly W, Richter E.
    Clin Pharmacol Ther; 1975 Oct 20; 18(4):433-40. PubMed ID: 1164825
    [Abstract] [Full Text] [Related]

  • 13. Enhanced plasma binding of propranolol and oxprenolol and induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the dog.
    Belpaire FM, Rosseel MT, De Rick A.
    Arch Int Pharmacodyn Ther; 1982 Oct 20; 259(2):303-4. PubMed ID: 7181586
    [No Abstract] [Full Text] [Related]

  • 14. Differential induction of antipyrine metabolism by rifampicin.
    Toverud EL, Boobis AR, Brodie MJ, Murray S, Bennett PN, Whitmarsh V, Davies DS.
    Eur J Clin Pharmacol; 1981 Oct 20; 21(2):155-60. PubMed ID: 7341283
    [Abstract] [Full Text] [Related]

  • 15. [Effect of rifampicin on the pharmacokinetics of tolbutamide in healthy subjects].
    Zilly W, Bopp E, Bürkl B, Richter E.
    Verh Dtsch Ges Inn Med; 1974 Oct 20; 80():1538-40. PubMed ID: 4454477
    [No Abstract] [Full Text] [Related]

  • 16. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M.
    Clin Pharmacol Ther; 1977 Mar 20; 21(3):301-9. PubMed ID: 837649
    [Abstract] [Full Text] [Related]

  • 17. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO, Foenander T, Wanwimolruk S, Gallus AS, Birkett DJ.
    Eur J Clin Pharmacol; 1982 Mar 20; 22(4):321-6. PubMed ID: 7106168
    [Abstract] [Full Text] [Related]

  • 18. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M, Vermeulen NP, Joeres RP, Breimer DD.
    Pharmacology; 1984 Mar 20; 29(2):99-109. PubMed ID: 6473507
    [Abstract] [Full Text] [Related]

  • 19. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia.
    Vermeulen NP, Danhof M, Setiawan I, Breimer DD.
    J Pharmacol Exp Ther; 1983 Jul 20; 226(1):201-5. PubMed ID: 6864540
    [Abstract] [Full Text] [Related]

  • 20. Letter: Rifampicin and drug metabolism.
    Syvälahti EK, Pihlajamäki KK, Iisalo EJ.
    Lancet; 1974 Jul 27; 2(7874):232-3. PubMed ID: 4135664
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.